Category: Joint ventures/collaborations
-
New Industry, Academic Studies Arrive at Space Station
Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions.
-
Whole Genome Sequencing Shown to Detect Neuro Disorders
An analysis of genetic database records indicates a class of neurological diseases can be detected by sequencing of a person’s entire genome.
-
ALS Therapy Start-Up Gains $5.1M in Seed Funds
A start-up enterprise is developing a treatment for amyotrophic lateral sclerosis or ALS, spun off from university research labs and an ALS advocacy group.
-
Challenge Seeks A.I. Antibody Enhancement Platform
A challenge competition is seeking computational biology teams to propose a new technology with artificial intelligence for enhancing antibody therapies.
-
Synthetic SARS-CoV-2 Particle Designed for Drug R&D
Two biotechnology companies created a synthetic non-infectious target model to represent SARS-CoV-2 viral variants for vaccine and therapy developers.
-
Start-Ups Partner on Quantum Computing and Longevity
Two companies formed in the last two years are applying quantum computing and artificial intelligence to discover new treatments for improving human longevity.
-
Group Devising Lower Cost Clinical Trials
A new not-for-profit organization aims to create a more efficient process for large-scale randomized clinical trials, to provide reliable results at lower cost.
-
Trial Shows Immunotherapy Improves Lung Cancer Survival
Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy.
-
National Lab, Software Company Partner on Net-Zero Microgrid
Idaho National Laboratory chose an energy software company to design a technology platform for local distribution of non-carbon electrical power.
-
Biotech, AI Company Partner on Covid-19 Alert System
A developer of Covid-19 vaccines and an artificial intelligence company are building a system to quickly detect dangerous SARS-CoV-2 variants.